Modulation of all-trans-retinoic acid administered on intermittent schedule by alpha-interferon 2a in a patient with AIDS-related Kaposi's sarcoma.
Toma
S
S
Iacona
I
I
Palumbo
R
R
Moresco
L
L
Raffo
P
P
Regazzi
M B
MB
D000163:Acquired Immunodeficiency Syndrome / Q000150:complications*; D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage*; D006801:Humans; D016898:Interferon-alpha / Q000008:administration & dosage*; D008297:Male; D012514:Sarcoma, Kaposi / Q000188:drug therapy* / Q000209:etiology; D014212:Tretinoin / Q000008:administration & dosage* / Q000493:pharmacokinetics
D016898:Interferon-alpha; D014212:Tretinoin